Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk
Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk
批准号:
10706558
负责人:
Saumya Das
金额:
$91.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-20 至 2026-06-30
关键词:
2&apos-DeoxythymidineAcinar CellAdultAnatomyAutophagocytosisBeta CellBiological ModelsBiologyCardiovascular DiseasesCause of DeathCell CommunicationCell LineCell physiologyCell secretionCellsCellular StressCellular biologyCessation of lifeCoculture TechniquesCommunicationCommunitiesComplementDataData SetDefectDevelopmentDiabetes MellitusDiseaseDisease ProgressionDuct (organ) structureDuctal Epithelial CellEmbryonic DevelopmentEndocrineEstersExhibitsExocrine pancreasExtracellular SpaceFunctional disorderGene MutationGenesGenetically Engineered MouseGoalsGrowthHip region structureHormonesHumanIncubatedInsulin-Dependent Diabetes MellitusIslet CellKidney FailureLabelLipaseMalignant NeoplasmsMalignant neoplasm of pancreasMetabolicModelingMolecularMorbidity - disease rateMutationOrganoidsOutcomeOutputPancreasPancreatic DiseasesPancreatitisPathogenesisPathway interactionsPatientsPhysiologyProcessPropertyReagentResearchResolutionResourcesRoleSecondary toSliceSmall RNATestingTherapeuticTissuesTransfer RNATransplantationVariantblood glucose regulationcell typecombatdiabetes riskendoplasmic reticulum stressexosomeexperimental studyextracellular vesiclesgene producthuman diseasehumanized mousein vitro Modelin vivoin vivo Modelinduced pluripotent stem cellinsightinsulin secretionintercellular communicationisletlipid disordermutantnon-diabeticnovelparacrinerisk variantsenescencestress granuletransmission processuptake
中文摘要
项目总结
1型糖尿病及其代谢后果仍然是最重要的生物医学研究之一
当今美国和世界面临的挑战。除了与糖尿病有关的疾病外,这种疾病
与肾功能衰竭、血脂紊乱、心血管疾病和癌症等并发症有关,而且
这是全球范围内的主要死因。因此,迫切需要更好地了解其发病机制。
这促进了分泌胰岛素的β细胞的丧失,以计划更好的治疗方法来对抗这种疾病。几个
研究认为,构成胰腺小窝的不同类型的细胞在胰腺癌的发病机制中起重要作用。
疾病的过程。从而更好地了解主要细胞之间的细胞间通信
腺泡细胞、导管细胞和胰岛细胞是必要的。我们已经研究了突变的羧酸酯的作用。
脂酶(CEL)基因在腺泡细胞中的表达对其被β细胞摄取并导致其缺陷的能力的影响
功能和成长。这项建议的目标是发现从腺泡分泌时所发生的变化
而导管细胞则与人胰岛和β细胞孵育。这些研究的数据将产生新的
用于测试的假设,将允许更深入地询问人体腺泡、导管和导管之间的串扰
胰岛细胞。在这项建议中,我们将解决以下目标:目标1)确定人的腺泡能力
直接影响胰岛细胞的功能。我们将从人类中分离和鉴定电动汽车
诱导多能干细胞(HIPS)来源的腺泡和导管谱系承诺的有机体,并孵化
用人胰岛/β细胞和人胰腺切片直接检测对胰岛细胞的影响
生物学。我们还将审查电动汽车货物,特别是来自转移RNA的片段。
目标2)我们将询问EVS的能力,EVS来源于髋关节产生的腺泡衍生的有机体
从MODY8患者的细胞中,直接调控人胰岛-β-细胞生物学。人类有机体的使用和
人类胰腺切片将为我们的研究提供翻译相关性。获得的结果和数据集
这些实验将补充人类岛屿研究网络的努力,并提供新的
与更大的科学界共享的资源。
英文摘要
PROJECT SUMMARY
Type 1 diabetes and its metabolic consequences continue to be among the most significant biomedical
challenges in the US and worldwide today. In addition to morbidities specifically related to diabetes the disease
is associated with complications such as renal failure, lipid disorders, cardiovascular disease and cancer and is
a major cause of death worldwide. Thus there is an urgent need for a better understanding of the pathogenesis
that promotes the loss of insulin-secreting beta cells to plan better therapeutics to combat the disease. Several
studies have argued that diverse cell types that make up the pancreatic niche contribute to the pathogenesis of
the disease process. Thus a better understanding of the inter-cellular communication between major cells such
as the acinar and duct cells and islet cells are warranted. We have studied the role of the mutant carboxy ester
lipase (CEL) gene, expressed in acinar cells, on its ability to be taken up by beta cells and cause defects in its
function and growth. The goal of this proposal is to discover the changes that occur when secretome from acinar
versus duct cells are incubated with human islet and β-cells. The data from these studies will generate new
hypothesis for testing that will allow a deeper interrogation of the cross-talk between human acinar, duct and
islet cells. We will address the following Aims in this proposal: Aim 1) Determine the ability of human acinar
versus human duct cells to directly impact islet cell function. We will isolate and characterize EVs, from human
induced pluripotent stem (hIPS) cell derived acinar- versus duct-lineage committed organoids, and incubate
them with human islet/β-cells and human pancreas slices to directly examine the consequences on islet cell
biology. We will also examine the EV cargo with a particular focus on fragments derived from transfer RNAs.
Aim 2) We will interrogate the ability of EVs, derived from acinar-derived organoids generated from the hiPS
cells from MODY8 patients, to directly regulate human islet-β-cell biology. The use of human organoids and
human pancreas slices will provide translational relevance of our studies. The results and datasets obtained
from these experiments will complement the efforts of the Human Islet Research Network and provide novel
resources to be shared with the larger scientific community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of beta-cell-specific extracellular vesicle cargo as functional biomarkers for type I DM disease
-
批准号:10517890
-
项目类别:
-
资助金额:$82.0万
-
财政年份:2022
-
负责人:Saumya Das
-
依托单位:
Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk
-
批准号:10594228
-
项目类别:
-
资助金额:$95.84万
-
财政年份:2022
-
负责人:Saumya Das
-
依托单位:
Characterization of beta-cell-specific extracellular vesicle cargo as functional biomarkers for type I DM disease
-
批准号:10706576
-
项目类别:
-
资助金额:$75.37万
-
财政年份:2022
-
负责人:Saumya Das
-
依托单位:
Functional role and therapeutic targeting of exosomes and extracellular RNA biomarkers in heart failure
-
批准号:9894484
-
项目类别:
-
资助金额:$96.07万
-
财政年份:2020
-
负责人:Saumya Das
-
依托单位:
Functional role and therapeutic targeting of exosomes and extracellular RNA biomarkers in heart failure
-
批准号:10417068
-
项目类别:
-
资助金额:$97.7万
-
财政年份:2020
-
负责人:Saumya Das
-
依托单位:
Functional role and therapeutic targeting of exosomes and extracellular RNA biomarkers in heart failure
-
批准号:10176560
-
项目类别:
-
资助金额:$98.54万
-
财政年份:2020
-
负责人:Saumya Das
-
依托单位:
Functional role and therapeutic targeting of exosomes and extracellular RNA biomarkers in heart failure
-
批准号:10630193
-
项目类别:
-
资助金额:$94.93万
-
财政年份:2020
-
负责人:Saumya Das
-
依托单位:
Molecular dissection and imaging of extracellular vesicles to define their origin and targets
-
批准号:10350010
-
项目类别:
-
资助金额:$110.01万
-
财政年份:2019
-
负责人:Saumya Das
-
依托单位:
Molecular dissection and imaging of extracellular vesicles to define their origin and targets
-
批准号:9811730
-
项目类别:
-
资助金额:$48.37万
-
财政年份:2019
-
负责人:Saumya Das
-
依托单位:
Molecular dissection and imaging of extracellular vesicles to define their origin and targets
-
批准号:10018945
-
项目类别:
-
资助金额:$45.49万
-
财政年份:2019
-
负责人:Saumya Das
-
依托单位:
Novel Therapy for Long QT Syndrome
-
批准号:9457493
-
项目类别:
-
资助金额:$59.92万
-
财政年份:2016
-
负责人:Saumya Das
-
依托单位:
Optimization of biofluid ex-RNA isolation and characterization.
-
批准号:8845766
-
项目类别:
-
资助金额:$7.42万
-
财政年份:2013
-
负责人:Saumya Das
-
依托单位:
Multi-group collaborative proposal: Diversity and function of prevalent uncharacterized exRNA species from tissue and biofluid
-
批准号:9452490
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2013
-
负责人:Saumya Das
-
依托单位:
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MI
-
批准号:9324478
-
项目类别:
-
资助金额:$4.33万
-
财政年份:2013
-
负责人:Saumya Das
-
依托单位:
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MI
-
批准号:8581981
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2013
-
负责人:Saumya Das
-
依托单位:
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MI
-
批准号:9128774
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2013
-
负责人:Saumya Das
-
依托单位:
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MI
-
批准号:8710366
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2013
-
负责人:Saumya Das
-
依托单位:
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MI
-
批准号:9059891
-
项目类别:
-
资助金额:$8.7万
-
财政年份:2013
-
负责人:Saumya Das
-
依托单位:
Computational discovery of SGK1 inhibitors for the treatment of heart disease
-
批准号:7976659
-
项目类别:
-
资助金额:$21.73万
-
财政年份:2010
-
负责人:Saumya Das
-
依托单位:
Computational discovery of SGK1 inhibitors for the treatment of heart disease
-
批准号:8091463
-
项目类别:
-
资助金额:$28.94万
-
财政年份:2010
-
负责人:Saumya Das
-
依托单位:
海外基金